Stay updated with breaking news from Published July. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Iterion Therapeutics, Inc., a venture-backed, clinical-stage biotechnology company developing novel cancer therapeutics, today announced the...
The pandemic has prompted improvements in mRNA platforms, continuous processing, formulation methods, and logistics that could benefit the vaccine field.
Precision NanoSystems maintains that mRNA and LNP technologies, microfluidics, and distributed manufacturing will revamp vaccine production.
New legislation will allow more innovative and human-relevant testing platforms to expedite the development of promising drugs.
